Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Tecan Group AG : Tecan appoints Dr. Stefan Traeger to the Management Board


Print article Print article
Copyright © Thomson Reuters 2013. All rights reserved.
2013-02-28 07:22:26 -

Tecan Group AG /
Tecan Group AG : Tecan appoints Dr. Stefan Traeger to the Management Board
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement. 

Männedorf, Switzerland, February 28, 2013 - The Tecan Group (SIX Swiss Exchange:
TECN) announced today that it has appointed Dr. Stefan Traeger as a member of
the Management Board. As Head of the Life Sciences Business division Stefan
Traeger will be responsible for the Group's global end-customer business. He
will take up his new post at Tecan on July 1, 2013. This position has been
vacant since summer 2012.

Stefan Traeger has extensive domain experience in a variety of management
positions in the life science industry. Since late 2007, he served as Managing
Director of 
Leica Microsystems CMS GmbH and as Vice President and General Manager of Leica's global Life Science Division. Prior to this, Stefan Traeger held a number of positions with increasing management responsibility in various areas within the Carl Zeiss Group between 2000 and the end of 2007, most recently as Director Strategic Business Development of Carl Zeiss Meditec and Managing Director of Carl Zeiss SMT Ltd. Tecan CEO David Martyr commented: "During our time together at Leica Microsystems, I came to know Stefan Traeger as a strong leader who has achieved significant successes. He resolutely aligned the Life Science division, the largest division at Leica Microsystems, to the needs of the market, increased sales considerably and raised profitability significantly. He also very successfully integrated two acquired companies into the existing business. We are delighted that Stefan Traeger will now bolster the Tecan management team in this vital position." Stefan Traeger holds a PhD from the University of Hannover, Germany, and an MBA from Purdue University. He is 45 years old and a German citizen. About Tecan Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2011, Tecan generated sales of CHF 377 million (USD 424 million; EUR 306 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019). For further information: Tecan Group Martin Brändle Head of Corporate Communications & Investor Relations Tel. +41 (0) 44 922 84 30 Fax +41 (0) 44 922 88 89 investor@tecan.com www.tecan.com Press Release (PDF): hugin.info/100384/R/1681569/549780.pdf This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Tecan Group AG via Thomson Reuters ONE [HUG#1681569]


Press Information:




Contact Person:


Disclaimer: © 2014 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com